- Corporate Officers - L
- Leonard John M
Insider Trading History of Leonard John M
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Leonard John M since 2013.
This trader's CIK number is 1563584.
At the time of last reporting, Leonard John M was the President and CEO of Intellia Therapeutics, Inc.. (stock ticker symbol NTLA).
Also see all insider trading activities at Intellia Therapeutics, Inc..
Note that in the past
LEONARD JOHN M also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Intellia Therapeutics, Inc. (NTLA) by Leonard John M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2025 | NTLA | 0 | $0 | 26,807 | $326,509 | 0 | $0 |
2024 | NTLA | 0 | $0 | 19,223 | $566,309 | 0 | $0 |
2023 | NTLA | 0 | $0 | 0 | $0 | 15,696 | $0 |
2022 | NTLA | 0 | $0 | 2,493 | $279,851 | 7,848 | $0 |
2021 | NTLA | 0 | $0 | 444,371 | $46,304,219 | 696,324 | $10,117,270 |
2020 | NTLA | 0 | $0 | 180,000 | $5,673,245 | 180,000 | $1,720,750 |
2018 | NTLA | 0 | $0 | 8,400 | $201,600 | 0 | $0 |
Yearly summary of insider trading at Abbvie Inc. (ABBV) by Leonard John M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2013 | ABBV | 0 | $0 | 74,649 | $2,844,820 | 76,350 | $2,157,169 |
Yearly summary of insider trading at Chimerix Inc (CMRX) by Leonard John M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2016 | CMRX | 0 | $0 | 5,000 | $25,165 | 0 | $0 |
2015 | CMRX | 1,000 | $47,380 | 0 | $0 | 0 | $0 |
2014 | CMRX | 4,000 | $116,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Iqvia Holdings Inc. (IQV) by Leonard John M
| | Insider Buying | Insider Sales | Option Exercises |
---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
---|
2019 | IQV | 0 | $0 | 20,200 | $3,090,600 | 20,200 | $1,308,354 |
Insider trading activities at 4 companies by Leonard John M:
1. Intellia Therapeutics, Inc. (NTLA)
2. Abbvie Inc. (ABBV)
3. Chimerix Inc (CMRX)
4. Iqvia Holdings Inc. (IQV)
Table 1. Insider trading of Intellia Therapeutics, Inc. (NTLA) by Leonard John M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2025-01-03 | NTLA | Sale | 26,807 | 12.18 | 326,509 |
2024-01-03 | NTLA | Sale | 19,223 | 29.46 | 566,309 |
2023-01-01 | NTLA | Option Ex | 7,848 | .00 | 0 |
2023-01-01 | NTLA | Option Ex | 7,848 | .00 | 0 |
2022-01-01 | NTLA | Option Ex | 7,848 | .00 | 0 |
2022-01-01 | NTLA | Sale | 2,493 | 112.25 | 279,851 |
2021-08-31 | NTLA | Sale | 37,833 | 155.00 | 5,864,115 |
2021-08-30 | NTLA | Sale | 38,804 | 156.86 | 6,086,679 |
2021-09-01 | NTLA | Sale | 44,735 | 170.00 | 7,604,950 |
2021-08-31 | NTLA | Option Ex | 37,833 | 14.58 | 551,605 |
2021-08-30 | NTLA | Option Ex | 38,804 | 13.99 | 542,867 |
2021-09-01 | NTLA | Option Ex | 44,735 | 20.88 | 934,066 |
2021-08-23 | NTLA | Option Ex | 27,139 | 13.40 | 363,662 |
2021-08-23 | NTLA | Sale | 27,139 | 152.71 | 4,144,478 |
2021-08-19 | NTLA | Option Ex | 22,682 | 13.40 | 303,938 |
2021-08-19 | NTLA | Sale | 22,682 | 151.44 | 3,434,962 |
2021-04-13 | NTLA | Option Ex | 25,937 | 10.36 | 268,577 |
2021-04-01 | NTLA | Option Ex | 71,041 | 13.99 | 993,863 |
2021-04-01 | NTLA | Sale | 38,209 | 83.50 | 3,190,451 |
2021-02-09 | NTLA | Sale | 28,043 | 75.00 | 2,103,225 |
2021-02-09 | NTLA | Option Ex | 56,718 | 6.83 | 387,383 |
2021-02-05 | NTLA | Sale | 22,942 | 67.94 | 1,558,679 |
2021-02-05 | NTLA | Option Ex | 40,000 | 13.40 | 536,000 |
2021-02-03 | NTLA | Sale | 67,856 | 72.50 | 4,919,560 |
2021-02-01 | NTLA | Option Ex | 200,000 | 15.45 | 3,089,600 |
2021-02-01 | NTLA | Sale | 109,889 | 64.14 | 7,048,610 |
2021-02-03 | NTLA | Option Ex | 117,060 | 18.33 | 2,145,709 |
2020-12-31 | NTLA | Option Ex | 14,375 | .00 | 0 |
2021-01-05 | NTLA | Sale | 6,239 | 55.86 | 348,510 |
2020-11-27 | NTLA | Option Ex | 35,000 | 16.44 | 575,400 |
2020-11-27 | NTLA | Sale | 35,000 | 38.50 | 1,347,500 |
2020-11-25 | NTLA | Option Ex | 50,000 | 6.83 | 341,500 |
2020-11-25 | NTLA | Sale | 50,000 | 36.00 | 1,800,000 |
2020-11-16 | NTLA | Option Ex | 20,000 | 14.58 | 291,600 |
2020-11-16 | NTLA | Sale | 20,000 | 34.00 | 680,000 |
2020-11-04 | NTLA | Sale | 50,000 | 26.00 | 1,300,000 |
2020-11-04 | NTLA | Option Ex | 50,000 | 6.83 | 341,500 |
2020-10-07 | NTLA | Option Ex | 5,000 | 6.83 | 34,150 |
2020-10-07 | NTLA | Sale | 5,000 | 21.83 | 109,149 |
2020-09-01 | NTLA | Sale | 5,000 | 21.83 | 109,149 |
2020-09-01 | NTLA | Option Ex | 5,000 | 6.83 | 34,150 |
2020-08-06 | NTLA | Sale | 5,000 | 21.83 | 109,149 |
2020-08-06 | NTLA | Option Ex | 5,000 | 6.83 | 34,150 |
2020-07-01 | NTLA | Option Ex | 5,000 | 6.83 | 34,150 |
2020-07-01 | NTLA | Sale | 5,000 | 21.83 | 109,149 |
2020-06-03 | NTLA | Option Ex | 5,000 | 6.83 | 34,150 |
2020-06-03 | NTLA | Sale | 5,000 | 21.83 | 109,149 |
2018-05-14 | NTLA | Sale | 8,400 | 24.00 | 201,600 |
Table 2. Insider trading of Abbvie Inc. (ABBV) by Leonard John M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2013-03-15 | ABBV | Option Ex | 46,700 | 28.86 | 1,347,902 |
2013-03-15 | ABBV | Sale | 46,700 | 38.45 | 1,795,615 |
2013-03-08 | ABBV | Sale | 27,949 | 37.54 | 1,049,205 |
2013-02-19 | ABBV | Option Ex | 29,650 | 27.29 | 809,267 |
Table 3. Insider trading of Chimerix Inc (CMRX) by Leonard John M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2016-09-15 | CMRX | Sale | 5,000 | 5.03 | 25,165 |
2015-08-21 | CMRX | Buy | 1,000 | 47.38 | 47,380 |
2014-11-05 | CMRX | Buy | 4,000 | 29.00 | 116,000 |
Table 4. Insider trading of Iqvia Holdings Inc. (IQV) by Leonard John M
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|
2019-12-20 | IQV | Option Ex | 20,200 | 64.77 | 1,308,354 |
2019-12-20 | IQV | Sale | 20,200 | 153.00 | 3,090,600 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Leonard John M
(President and CEO of Intellia Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.